Overview
Akamis Bio is working to advance the standard of care in colorectal cancer by developing oncolytic immunotherapies aimed at providing new treatment options for patients.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Akamis Bio in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.